
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Insurers from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/insurers/topic/17981/</link>
        <description>Articles tagged with Insurers from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Studies show cheaper drugs don&apos;t add up to greater use</title>
          <description>Two studies released show that the story behind lower consumer healthspend isn&apos;t about generics improving health.</description>
          <link>http://www.mmm-online.com/studies-show-cheaper-drugs-dont-add-up-to-greater-use/article/292626/</link>
          <pubDate>Thu, 09 May 2013 16:09:46 GMT</pubDate>
          <itunes:summary>Two studies released show that the story behind lower consumer healthspend isn&apos;t about generics improving health.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: AstraZeneca, Novartis, Teva</title>
          <description>AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing&apos;s, and Teva ventures into South Korea. Plus: a closer look at health exchanges</description>
          <link>http://www.mmm-online.com/company-news-astrazeneca-novartis-teva/article/272860/</link>
          <pubDate>Mon, 17 Dec 2012 17:17:53 GMT</pubDate>
          <itunes:summary>AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing&apos;s, and Teva ventures into South Korea. Plus: a closer look at health exchanges</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>HHS expands 9/11 health program to cover cancers</title>
          <description>The Department of Health and Human Services observed the anniversary of the September 11, 2001 attacks by extending coverage of a program for first responders sickened by their work at Ground Zero, the Pentagon and the Flight 93 crash site in Shanksville, PA to cover some 50 cancers.</description>
          <link>http://www.mmm-online.com/hhs-expands-911-health-program-to-cover-cancers/article/258553/</link>
          <pubDate>Tue, 11 Sep 2012 20:30:22 GMT</pubDate>
          <itunes:summary>The Department of Health and Human Services observed the anniversary of the September 11, 2001 attacks by extending coverage of a program for first responders sickened by their work at Ground Zero, the Pentagon and the Flight 93 crash site in Shanksville, PA to cover some 50 cancers.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Amid misspent billions, the promise of personalized medicine</title>
          <description>The Institute of Medicine has released a report putting the cost of unnecessary medical care at $750 billion a year and counting. What does it mean for pharmas? Depends on how you read it.</description>
          <link>http://www.mmm-online.com/amid-misspent-billions-the-promise-of-personalized-medicine/article/258368/</link>
          <pubDate>Mon, 10 Sep 2012 19:41:05 GMT</pubDate>
          <itunes:summary>The Institute of Medicine has released a report putting the cost of unnecessary medical care at $750 billion a year and counting. What does it mean for pharmas? Depends on how you read it.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharmas are from Mars, Payers are from Venus</title>
          <description>Pharma needs to step up its sales pitch, looking beyond a drug&apos;s top attributes, to convince payers that their drugs are worth the cost.</description>
          <link>http://www.mmm-online.com/pharmas-are-from-mars-payers-are-from-venus/article/241644/</link>
          <pubDate>Thu, 17 May 2012 19:17:06 GMT</pubDate>
          <itunes:summary>Pharma needs to step up its sales pitch, looking beyond a drug&apos;s top attributes, to convince payers that their drugs are worth the cost.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  